Page last updated: 2024-08-18

4-butyrolactone and Thyroid Neoplasms

4-butyrolactone has been researched along with Thyroid Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, M; Al-Dayel, F; Al-Kuraya, KS; Al-Nuaim, A; Al-Rasheed, M; Al-Sobhi, S; Bavi, P; Bu, R; Hussain, AR; Myers, JN; Siraj, AK; Uddin, S1

Other Studies

1 other study(ies) available for 4-butyrolactone and Thyroid Neoplasms

ArticleYear
Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:10

    Topics: 4-Butyrolactone; Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Carcinoma, Papillary; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acid Synthases; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Thyroid Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2008